Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$223,369
-$29,169 QoQ
Shares Held
1,768
-2.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,859
of 2,266 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026McLean Asset Management Corp holds $5,605,267 across 9 Drug Manufacturers - General names. GILD ranks #8 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,420 | $1,703,190 | |
| 2 | JNJ |
Johnson & Johnson
|
3,218 | $817,275 | |
| 3 | ABBV |
AbbVie Inc.
|
3,136 | $789,143 | |
| 4 | AZN |
Astrazeneca PLC
|
3,240 | $614,368 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,870 | $497,295 | |
| 6 | AMGN |
Amgen Inc
|
1,064 | $385,295 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,472 | $372,916 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
1,768 | $223,369 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $223,369 | 1,768 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $252,538 | 1,812 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $220,563 | 1,797 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $198,024 | 1,784 | Shares | Sole | 2025-10-07 | |
| No filing history on record for this holder in this stock. | ||||||